Symptoms or abnormal findings
Persistent indigestion, weight loss, anemia, vomiting, black stools, abdominal pain or abnormal imaging may lead to further evaluation.
Stomach cancer diagnosis and staging help confirm whether a gastric tumor is present, define the cancer type, identify important biomarkers, measure how deeply the tumor has grown into the stomach wall, check nearby lymph nodes and determine whether cancer has spread to distant organs or the peritoneum.
Stomach cancer is usually confirmed by examining tissue from the stomach under a microscope. Endoscopy helps doctors see the stomach lining and take biopsy samples. Imaging and other tests help determine stage and treatment planning.
Persistent indigestion, weight loss, anemia, vomiting, black stools, abdominal pain or abnormal imaging may lead to further evaluation.
Upper endoscopy allows direct visualization of the stomach lining and biopsy of suspicious areas.
Pathology confirms cancer type. Imaging, endoscopic ultrasound and staging procedures help define tumor depth, lymph nodes and metastasis.
The exact diagnostic pathway depends on symptoms, age, risk factors, endoscopy findings, biopsy results, tumor location and whether cancer appears localized, regional or metastatic.
The care team reviews symptoms, weight change, appetite, bleeding signs, anemia, family history, H. pylori history, reflux and prior endoscopy results.
A thin flexible scope is passed through the mouth to inspect the esophagus, stomach and first part of the small intestine.
Small tissue samples are taken from suspicious stomach areas. Biopsy is used to confirm whether cancer is present.
Pathology identifies adenocarcinoma or another tumor type and may report grade, histologic pattern, invasion and biomarker testing.
CT, PET/CT, MRI or endoscopic ultrasound may help estimate tumor extent, wall invasion, lymph nodes and distant spread.
In selected cases, laparoscopy may check for small peritoneal spread that may not be visible on imaging.
Tests may include endoscopy, biopsy, pathology, imaging, endoscopic ultrasound, laparoscopy and blood tests. ACS states that tests for stomach cancer may include endoscopy, biopsy, imaging tests and lab tests.
Directly examines the stomach lining and allows biopsy of abnormal areas.
Removes tissue for microscopic examination. Biopsy is central to confirming a stomach cancer diagnosis.
Determines tumor type, grade, histologic features and sometimes molecular or biomarker results.
Uses ultrasound from inside the digestive tract to estimate tumor depth and nearby lymph-node involvement.
Helps assess stomach wall thickening, lymph nodes, nearby organs, liver lesions or other signs of spread.
May help identify metabolically active disease or distant spread in selected staging situations.
A minimally invasive procedure that may identify peritoneal disease not visible on scans.
May assess anemia, liver function, nutrition, inflammation and overall treatment readiness.
Imaging can suggest stomach wall thickening or spread, but the diagnosis of gastric cancer is confirmed by tissue examination. Endoscopy allows direct inspection of the gastric mucosa and targeted biopsy.
Doctors can inspect ulcers, masses, thickened folds, bleeding areas or abnormal mucosa.
Pathologists examine tissue architecture and cell features to confirm cancer type.
HER2, MSI/MMR, PD-L1, EBV or CLDN18.2 testing may be relevant depending on case and care setting.
Stomach cancer staging usually uses the TNM system. TNM describes the primary tumor depth, lymph-node involvement and whether cancer has spread to distant body sites. NCI states that TNM results are used to assign stage I, II, III or IV.
Describes how deeply the tumor has grown into the stomach wall and whether it reaches nearby structures.
Describes whether stomach cancer has spread to nearby regional lymph nodes and how many nodes are involved.
Describes whether cancer has spread to distant organs, distant lymph nodes or the peritoneum.
Stage grouping summarizes the TNM pattern. Lower stage generally means less spread; higher stage means deeper invasion, more lymph-node involvement or distant spread.
Abnormal cells are limited to the inner lining and have not invaded deeper stomach wall layers.
Early invasive stomach cancer, often limited to inner layers or with limited regional node involvement.
Cancer has grown more deeply or involves more nearby lymph nodes, but distant spread is not present.
Cancer usually involves deeper stomach wall invasion, nearby structures or more regional lymph nodes.
Cancer has spread to distant organs, distant lymph nodes or the peritoneum. This is also called metastatic stomach cancer.
Pathology confirms cancer type and may include features used in staging, prognosis, tumor classification and treatment discussions.
Gastric adenocarcinoma, diffuse-type, intestinal-type, signet-ring, GIST, lymphoma or neuroendocrine tumor.
Describes how abnormal cancer cells look and how closely they resemble normal gland cells.
Helps determine the T category when surgical tissue is available.
Reports whether cancer cells are seen in blood vessels or lymphatic channels.
After resection, margins show whether cancer cells are present at the tissue edge.
HER2, MSI/MMR, PD-L1, EBV and CLDN18.2 may be tested depending on clinical context.
Select a topic to reveal practical questions for endoscopy, biopsy, imaging, biomarkers, staging or pathology appointments.
Diagnosis confirms whether cancer is present. Staging explains how far stomach cancer has grown or spread.
Stomach cancer is usually diagnosed with upper endoscopy and biopsy. A pathologist examines the tissue under a microscope.
Tests may include CT, PET/CT, MRI, endoscopic ultrasound, laparoscopy and blood tests depending on the case.
TNM means Tumor, Nodes and Metastasis. It describes tumor depth, lymph-node spread and distant spread.
Clear answers to common diagnosis and staging search questions.
Stomach cancer is usually diagnosed by upper endoscopy with biopsy. The biopsy sample is examined by a pathologist to confirm whether cancer is present.
A CT scan can show suspicious findings and help stage disease, but tissue biopsy is needed to confirm a stomach cancer diagnosis.
Endoscopic ultrasound helps estimate how deeply a stomach tumor has grown into the stomach wall and whether nearby lymph nodes may be involved.
Stomach cancer is usually staged with the TNM system, which describes tumor depth, lymph-node involvement and distant metastasis.
No. This page is educational only and does not replace consultation with a qualified healthcare professional.
Authoritative sources used to support this stomach cancer diagnosis and staging page.